Abbott Laboratories (ABT) Cash & Current Investments (2009 - 2026)
Abbott Laboratories (ABT) posted Cash & Current Investments of $5.6 billion for Q2 2026, down 23.19% sequentially from $7.3 billion in Q1 2026, and down 23.06% YoY from $7.3 billion in Q2 2025.
Abbott Laboratories (ABT) Cash & Current Investments (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Cash & Current Investments for 18 years, with the latest figure at $5.6 billion in Q2 2026.
- Quarterly Cash & Current Investments fell 23.06% year-over-year to $5.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.6 billion (down 23.06% YoY) and the FY2025 annual result came in at $8.9 billion, up 12.2% from the prior year.
- Cash & Current Investments slipped to $5.6 billion in Q2 2026 per ABT's latest filing, from $7.3 billion in the prior quarter.
- Over five years, Cash & Current Investments peaked at $10.2 billion in Q4 2022 and troughed at $5.6 billion in Q2 2026.
- A 5-year average of $7.9 billion and a median of $7.8 billion in 2024 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2023 and 2024: Cash & Current Investments climbed 16.84% in 2023, then slumped 30.22% in 2024.
- Over 5 years, Cash & Current Investments stood at $10.2 billion in 2022, then retreated by 28.43% to $7.3 billion in 2023, then climbed by 9.45% to $8.0 billion in 2024, then gained by 12.2% to $8.9 billion in 2025, then tumbled by 37.32% to $5.6 billion in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $5.6 billion, $7.3 billion, and $8.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.60 Bn |
| Mar 31, 2026 | 7.30 Bn |
| Dec 31, 2025 | 8.94 Bn |
| Sep 30, 2025 | 7.73 Bn |
| Jun 30, 2025 | 7.28 Bn |
| Mar 31, 2025 | 6.84 Bn |
| Dec 31, 2024 | 7.97 Bn |
| Sep 30, 2024 | 7.79 Bn |
| Jun 30, 2024 | 7.22 Bn |
| Mar 31, 2024 | 6.65 Bn |
| Dec 31, 2023 | 7.28 Bn |
| Sep 30, 2023 | 7.05 Bn |
| Jun 30, 2023 | 8.16 Bn |
| Mar 31, 2023 | 9.53 Bn |
| Dec 31, 2022 | 10.17 Bn |
| Sep 30, 2022 | 9.91 Bn |
| Jun 30, 2022 | 9.29 Bn |
| Mar 31, 2022 | 8.16 Bn |
| Dec 31, 2021 | 10.25 Bn |
| Sep 30, 2021 | 9.69 Bn |